Herbenick Michael A, Sprott Dominic, Stills Harold, Lawless Matthew
Department of Orthopaedic Surgery, Wright State University School of Medicine, Dayton, OH 45409, USA.
Am J Orthop (Belle Mead NJ). 2008 Jul;37(7):E133-7.
Since the advent of cyclooxygenase 2 (COX-2) inhibitors, little research has been done on the effects of these medications on fracture healing. In the study reported here, we sought to determine whether a COX-2 inhibitor, celecoxib, affects strength and amount of healing callus formed after a fracture. Forty-eight male Sprague-Dawley rats were evaluated for impairment of fracture healing with celecoxib use. Compared with controls, celecoxib-treated rats had a significant decrease in force required for refracture (P = .0199). We do not recommend routine use of celecoxib in postfracture pain control, particularly when fracture union is tenuous.
自环氧化酶2(COX-2)抑制剂问世以来,关于这些药物对骨折愈合影响的研究甚少。在本文报道的研究中,我们试图确定一种COX-2抑制剂塞来昔布是否会影响骨折后形成的愈合骨痂的强度和数量。对48只雄性斯普拉格-道利大鼠使用塞来昔布后评估其骨折愈合受损情况。与对照组相比,接受塞来昔布治疗的大鼠再次骨折所需的力显著降低(P = 0.0199)。我们不建议在骨折后疼痛控制中常规使用塞来昔布,尤其是在骨折愈合不牢固时。